CD5 (Mantle Cell Lymphoma Marker)(B-B8), 0.2mg/mL [26628-22-8]

Biotium

CD5 (Mantle Cell Lymphoma Marker)(B-B8), 0.2mg/mL [26628-22-8]

9

Functional Assay, Flow Cytometry, ImmunoFluorescence

26628-22-8

Research Use Only

Monoclonal

B-B8

0.2 mg/ml

CD5

CD5 molecule

LEU1, T1, T-cell surface glycoprotein CD5, CD5 antigen (p56-62), epididymis secretory sperm binding protein, lymphocyte antigen T1/Leu-1

Mouse

IgG1

T-cell surface glycoprotein CD5

This antibody recognizes a 67 kDa transmembrane protein which is identified as CD5. The CD5 antigen is found on 95% of thymocytes and 72% of peripheral blood lymphocytes. In lymph nodes, the main reactivity is observed in T cell areas. Anti-CD5 is a pan T-cell marker that also reacts with a range of neoplastic B-cells, e.g. chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), mantle cell lymphoma, and a subset (~10%) of diffuse large B-cell lymphoma. CD5 aberrant expression is useful in making a diagnosis of mature T-cell neoplasms. Note that this MAb is not suitable for frozen tissues.

Animal

Bovine, Human, Mouse

2°C to 8°C,RT

41116161